NovoCure Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include Silverback Therapeutics and Legend Biotech.
Lyell
Lyell
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
Silverback Therapeutics
Silverback Therapeutics
Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.
Legend Biotech
Legend Biotech
Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
Founding Date
Founding Date
2018
Founding Date
2016
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Bothell, US
Seattle, US
Locations
Seattle, US HQ
Locations
Somerset, US HQ
Ghent, BE
Nanjing, CN
Hong Kong, HK
Dublin, IE
Piscataway, US
Employees
Employees
188
Employees
9067% increase
Employees
2,90012% increase
Valuation ($)
Valuation ($)
243.3 m
Valuation ($)
550.4 m
Valuation ($)
8.4 b

Financial

Revenue (est.)
Revenue (est.)
$36k (FY, 2025)
Revenue (est.)
$1.3m (FY, 2022)
Revenue (est.)
$1b (FY, 2025)
Net income
Net income
($274.4m) (FY, 2025)
Net income
($34.7m) (FY, 2022)
Net income
($296.8m) (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 211m
Total funding raised
$ 150.5m
For sources of this data, please see the company profile

View Company Profiles

Silverback Therapeutics
HQ
Seattle, US
Employees
90

Silverback Therapeutics is a biotech company developing treatments for cancer, fibrosis, and infectious diseases.

View company
Legend Biotech
HQ
Somerset, US
Employees
2,900↑ 12% increase

Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.

View company